# Immunotherapy of Melanoma With Tumor Antigen RNA and Small Inhibitory RNA Transfected Autologous Dendritic Cells

> **NCT00672542** · PHASE1 · COMPLETED · sponsor: **Scott Pruitt** · enrollment: 12 (actual)

## Conditions studied

- Metastatic Melanoma
- Absence of CNS Metastases

## Interventions

- **BIOLOGICAL:** Proteasome siRNA and tumor antigen RNA-transfected dendritic cells

## Key facts

- **NCT ID:** NCT00672542
- **Lead sponsor:** Scott Pruitt
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-01
- **Primary completion:** 2013-03
- **Final completion:** 2013-07
- **Target enrollment:** 12 (ACTUAL)
- **Last updated:** 2014-01-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00672542

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00672542, "Immunotherapy of Melanoma With Tumor Antigen RNA and Small Inhibitory RNA Transfected Autologous Dendritic Cells". Retrieved via AI Analytics 2026-09-03 from https://api.ai-analytics.org/clinical/NCT00672542. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*